Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Biagini

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|October 29, 2010
Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: toward combination chemotherapy of malaria through a single chemical entityPeter Gibbons, Edite Verissimo, Nuna C Araujo, et al.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Chandrakala Pidathala, Richard Amewu, Bénédicte Pacorel, et al.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Suet C Leung, Peter Gibbons, Richard Amewu, et al.
Molecular Biology and Evolution|September 13, 2024
Low Genetic Impact of the Roman Occupation of Britain in Rural CommunitiesChristiana L Scheib, Ruoyun Hui, Alice K Rose, et al.
Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2023
Lack of antiviral activity of probenecid in vitro and in Syrian golden hamstersHelen J Box, Joanne Sharp, Shaun H Pennington, et al.
Bioorganic & Medicinal Chemistry|May 22, 2018
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malariaPaul M O' Neill, Paul A Stocks, Sunil Sabbani, et al.
Journal of Medicinal Chemistry|March 3, 2012
Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methodsRaman Sharma, Alexandre S Lawrenson, Nicholas E Fisher, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|October 29, 2010
Endoperoxide carbonyl falcipain 2/3 inhibitor hybrids: toward combination chemotherapy of malaria through a single chemical entityPeter Gibbons, Edite Verissimo, Nuna C Araujo, et al.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Chandrakala Pidathala, Richard Amewu, Bénédicte Pacorel, et al.
Journal of Medicinal Chemistry|February 28, 2012
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)Suet C Leung, Peter Gibbons, Richard Amewu, et al.
Molecular Biology and Evolution|September 13, 2024
Low Genetic Impact of the Roman Occupation of Britain in Rural CommunitiesChristiana L Scheib, Ruoyun Hui, Alice K Rose, et al.
Clinical Pharmacology and Therapeutics|May 22, 2020
Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human PharmacokineticsUsman Arshad, Henry Pertinez, Helen Box, et al.
British Journal of Clinical Pharmacology|October 21, 2020
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxisRajith K R Rajoli, Henry Pertinez, Usman Arshad, et al.
ACS Infectious Diseases|January 6, 2023
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>Laura N Jeffreys, Alison Ardrey, Taghreed A Hafiz, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2023
Lack of antiviral activity of probenecid in vitro and in Syrian golden hamstersHelen J Box, Joanne Sharp, Shaun H Pennington, et al.
Bioorganic & Medicinal Chemistry|May 22, 2018
Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malariaPaul M O' Neill, Paul A Stocks, Sunil Sabbani, et al.
Journal of Medicinal Chemistry|March 3, 2012
Identification of novel antimalarial chemotypes via chemoinformatic compound selection methods for a high-throughput screening program against the novel malarial target, PfNDH2: increasing hit rate via virtual screening methodsRaman Sharma, Alexandre S Lawrenson, Nicholas E Fisher, et al.
Pageof 22